Statistics for A Recombinant Dimethylarginine Dimethylaminohydrolase-1–Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity
Total visits
| views | |
|---|---|
| A Recombinant Dimethylarginine Dimethylaminohydrolase-1–Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity | 82 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Lee2022Recombinant-AAM.pdf | 123 |
Top country views
| views | |
|---|---|
| United States | 70 |
| China | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
| Romania | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 45 |
| Fairfield | 7 |
| White Plains | 4 |
| Cambridge | 2 |
| Houston | 2 |
| Ann Arbor | 1 |
| Bucharest | 1 |
| Kuala Lumpur | 1 |
| Mount Laurel | 1 |
| Raleigh | 1 |
| Tustin | 1 |
| Westbury | 1 |